Price target
612.530.000.00%
The 23 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 29 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
RGO EPS for the last quarter is 9.42 CHF despite the estimation of 7.69 CHF. In the next quarter EPS is expected to reach 8.53 CHF. Track more of Regeneron Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Regeneron Pharmaceuticals, Inc. revenue is expected to reach 3.02 B CHF. Check out Regeneron Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, RGO price target is 612.53 CHF with a max estimate of 733.93 CHF and a min estimate of 496.01 CHF. Check if this forecast comes true in a year, meanwhile watch Regeneron Pharmaceuticals, Inc. stock price chart and keep track of the current situation with RGO news and stock market news.
We've gathered opinions of 29 analysts rating RGO stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.